
Keywords: کریوتایپینگ طیفی; MDS; myelodysplastic syndromes; AML; acute myeloid leukemia; AZA; azacitidine; DEC; decitabine; LEN; lenalidomide; HI; hematological improvement; SKY; spectral karyotyping; CNV; copy number variation; IWG; International Working Group; HMA; hypomethylating